CD23

Overview

CD23 (FcεRII, low-affinity IgE receptor) is expressed on resting naive and transitional B cells and is downregulated upon sustained B cell activation. In flow cytometry, CD23 expression status (CD23⁺ vs. CD23⁻) within the IgD⁺CD27⁻ naive compartment can help discriminate resting naive cells from recently activated naive cells. CD23 downregulation is induced by sustained BCR signalling, TLR9 activation, IFN-α, and IFN-γ — all pathways active in SLE and in acute viral infections.

Key Points from Literature

  • CD23⁻ phenotype marks acN cells in SLE: Activated naive (acN) B cells (CD19^hi, IgD⁺, CD27⁻, MTG⁺, CD24⁻, CD21⁻) are CD23⁻, consistent with downregulation by sustained activation pathways. Longitudinal tracking of CD23⁻ cells within the IgD⁺CD27⁻ naive compartment of SLE patients showed correlation with disease activity across moderate and severe flares (see Tipton2015 - ASC Diversity and Origin in SLE, 13 longitudinal experiments across 3 patients).

  • CD23 downregulation by activation stimuli: CD23 expression is reduced by sustained BCR activation, TLR9 stimulation, IFN-α, and IFN-γ — signalling pathways prominent in SLE. This mechanistic basis suggests CD23⁻ cells within the naive compartment are not a fixed developmental subset but reflect ongoing activation state (see Tipton2015 - ASC Diversity and Origin in SLE, citing Hanten et al. 2008 and Delespesse et al. 1989).

  • Potential utility as a disease-activity marker: CD23 negativity within the IgD⁺CD27⁻ gate was used as a surrogate for acN cell frequency in longitudinal analyses, as it requires fewer reagents than the full MTG + CD24 panel. Changes in CD23⁻ frequency tracked with flare severity (see Tipton2015 - ASC Diversity and Origin in SLE).

  • CD23⁻ is part of the founding murine ABC definition (Hao et al. 2011). ABCs were defined as B220⁺CD19⁺ splenic B cells lacking CD21, CD23, CD95, and CD43 (see Cancro2020 - Age-Associated B Cells, review — no original data; mouse).

  • The CD21⁻CD23⁻ gate is heterogeneous, not a single population. Within this gate, only ~2/3 of cells are T-bet⁺, and among those only about half are CD11c⁺ — at least three populations sit inside a CD21⁻CD23⁻ gate, and whether they are stable subsets or differentiation stages of one lineage is unresolved (see Cancro2020 - Age-Associated B Cells, review — no original data; mouse, splenic).

  • CD23 loss travels with CD21 loss under IFN-γ, which makes CD23⁻ expansions ambiguous. In the review’s adapted in vitro data, stimulating healthy-donor naive B cells with R848 + cytokines + IFN-γ but not IL-4 produced plasma cell differentiation with increased T-bet and CD11c and concomitant loss of both CD21 and CD23. Because CD23 is mainly IL-4-induced after BCR or CD40 stimulation, the review reads CD23⁻ expansions in SLE as possibly activated naive cells rather than a distinct lineage — the same activation-not-identity caution the wiki now carries for CD21, CD11c and CD71. Table 1 gives activated naive as CD95⁺CD23⁻CD11c⁺T-bet⁺ (see Sanz2019 - Consistent Classification of Human B Cell Populations, review — no original data). See Activated Naive B Cell.

Contradictions & Debates

  • CD23 downregulation can occur by multiple mechanisms (shedding, transcriptional repression) and is not restricted to acN cells — it may also mark other activated B cell subsets. Its specificity as a surrogate for acN cells has not been formally validated against the full MTG/CD24 gating scheme.

Activated Naive B Cell, CD21, CD24, Extrafollicular Response, Conventional Flow Cytometry

Sources